Publications by authors named "J Janda"

Claim this Profile
5
5-Hydroxytryptamine 1F receptor loss reduces renal vasculature and prevents lasmiditan-induced recovery following moderate-severe acute kidney injury in mice.
Austin D Thompson, Kai W McAlister, Natalie E Scholpa, Jaroslav Janda, John Hortareas

Am J Physiol Renal Physiol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
MARY1 restores mitochondrial homeostasis and accelerates renal recovery following acute kidney injury.
Paul Victor Santiago Raj, Jaroslav Janda, Natalie E Scholpa, Kevin A Hurtado, Rick G Schnellmann

Am J Physiol Renal Physiol· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A group with emerging potential in the clinical and public health realms: the genus .
J Michael Janda

Infect Dis (Lond)· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of a Novel, Potent, and Selective 5‑Hydroxytryptamine 2B Receptor Antagonist that Induces Mitochondrial Biogenesis in the Kidney.
Paul Victor Santiago Raj, Giri Gnawali, Jaroslav Janda, Natalie E Scholpa, Vishal Kaleeswaran

ACS Pharmacol Transl Sci· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lasmiditan induces mitochondrial biogenesis in primary mouse renal peritubular endothelial cells and augments wound healing and tubular network formation.
Austin D Thompson, Kai W McAlister, Natalie E Scholpa, Jaroslav Janda, John Hortareas

Am J Physiol Cell Physiol· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis